Overview

Levetiracetam in the Management of Bipolar Depression

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
A 6-week outpatient, double-blind, placebo-controlled, add-on trial to investigate the effects of levetiracetam on depressive symptoms in bipolar depressed patients.
Phase:
N/A
Details
Lead Sponsor:
Yale University
Collaborator:
Stanley Medical Research Institute
Treatments:
Etiracetam
Levetiracetam
Piracetam